iFlash-SARS-CoV-2 IgM

Manufactured by SHENZHEN YHLO BIOTECH Co. Ltd., China - http://www.szyhlo.com 

Related Scientific Literature

• Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan
• Diagnostic performances and thresholds: the key to harmonization in serological SARS-CoV-2 assays?
• Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis
• Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019
• Closing the Serological Gap in the Diagnostic Testing for COVID-19: The Value of Anti-SARS-CoV-2 IgA Antibodies
• Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience
• Detection of IgM and IgG antibodies in patients with coronavirus disease 2019
• Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies
• COVID-19 Serological Tests: How Well Do They Actually Perform?
• Genetics of Severe Acute Respiratory Syndrome Coronavirus-2 and Diagnosis of Coronavirus Disease-2019: An Overview
• Antibody tests in detecting SARS-CoV-2 infection: A meta-analysis
• Assay Techniques and Test Development for COVID-19 Diagnosis.
• Review of Current Advances in Serologic Testing for COVID-19
• Profile of Specific Antibodies to SARS-CoV-2: The First Report.
• Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
• Comparison of sixteen serological SARS-CoV-2 immunoassays in sixteen clinical laboratories

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements